Goldman Sachs’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Goldman Sachs’s Portfolio ISLE Stock Details ISLE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-784,204	Closed	-$7.81M	–	6815
2022 Q2	$7.81M	Hold	784,204	–	–	﹤0.01%	2735
2022 Q1	$7.76M	Buy	784,204 +40,456	+5%	+$399K	﹤0.01%	2946
2021 Q4	$7.32M	Hold	743,748	–	–	﹤0.01%	3056
2021 Q3	$7.31M	Buy	743,748 +59,961	+9%	+$585K	﹤0.01%	3017
2021 Q2	$6.7M	Buy	683,787 +196,573	+40%	+$1.92M	﹤0.01%	3079
2021 Q1	$4.72M	Buy	+487,214	New	+$4.71M	﹤0.01%	3191

Goldman Sachs's ISLE Position: Q3 2022 in Review

Goldman Sachs sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 784,204 shares — an estimated $7.81M sold.

Goldman Sachs first reported a position in ISLE in Q1 2021 and held it in 6 quarters. The position peaked at $7.81M in Q2 2022. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

Goldman Sachs reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
Goldman Sachs sold 784,204 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $7.81M.
Goldman Sachs first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q1 2021 and held it in 6 quarters.
Goldman Sachs's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $7.81M in Q2 2022.
0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.